Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Full description

Bibliographic Details
Main Authors: Madeleine D. Burns, Brittany P. Boribong, Yannic C. Bartsch, Maggie Loiselle, Kerri J. St. Denis, Maegan L. Sheehan, Jessica W. Chen, Jameson P. Davis, Rosiane Lima, Andrea G. Edlow, Alessio Fasano, Alejandro B. Balazs, Galit Alter, Lael M. Yonker
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
pediatrics
adolescents
vaccines
boosters
Online Access:https://www.mdpi.com/2076-393X/10/4/492

Internet

https://www.mdpi.com/2076-393X/10/4/492

Similar Items